Izervay by Astellas and Syfovre by Apellis are the major rivals in the United St...
Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney ...
A mid-phase trial featuring Gilead Sciences and Merck & Co.’s once-weekly HIV co...
The latest research on Arcus Biosciences’ experimental HIF-2a inhibitor suggests...
Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after i...
Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit...
Common conditions in women such as PCOS, menopause, and endometriosis often lead...
Novartis is investing over $70 million in Chengdu Baiyu Pharmaceutical to bolste...
The Food and Drug Administration (FDA) has recently granted approval to Swiss co...
After last year’s Nobel Prize in Physiology or Medicine was awarded to Drew Weis...
A large phase 3 study conducted over GSK’s RSV vaccine Arexvy has shown how the ...
Maven Clinic, an online clinic for women and family health, has closed its serie...
Regulators around the world are increasing their scrutiny of medical devices as ...
Scholar Rock Inc has announced that the phase 3 trial of Apitegromab for spinal ...
Johnson & Johnson’s SunRISe-2 study has officially been discontinued. Johnson & ...
In a recent move, Editas sold part of these rights to DRI Healthcare’s subsidiar...
